
Tidutamab
CAS No. 2148354-90-7
Tidutamab( —— )
Catalog No. M36789 CAS No. 2148354-90-7
Tidutamab (XmAb-18087) is a humanized bispecific antibody targeting the growth inhibitory receptor 2 (SSTR2) and T-cell binding domain (CD3) with antitumor activity for the study of gastric neurosecretory tumors.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 676 | Get Quote |
![]() ![]() |
5MG | 1311 | Get Quote |
![]() ![]() |
10MG | 2119 | Get Quote |
![]() ![]() |
25MG | 3846 | Get Quote |
![]() ![]() |
50MG | 5216 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameTidutamab
-
NoteResearch use only, not for human use.
-
Brief DescriptionTidutamab (XmAb-18087) is a humanized bispecific antibody targeting the growth inhibitory receptor 2 (SSTR2) and T-cell binding domain (CD3) with antitumor activity for the study of gastric neurosecretory tumors.
-
DescriptionTidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). Tidutamab possesses a full Fc domain to maintain long serum half-life.Tidutamab eliminates SSTR+ tumor cells by stimulating redirected T cellmediated cytotoxicity (RTcC).
-
In Vitro——
-
In VivoAnimal Model:NSG mice Dosage:3 mg/kg Administration:Intraperitoneal injection; single dose Result:lnduced anti-tumor activity in human PBMC-engrafted NSG mice.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2148354-90-7
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hyung LS, et, al. Anti-SSTR2 × anti-CD3 bispecific antibody induces potent killing of human tumor cells?in vitro?and in mice, and stimulates target-dependent T cell activation in monkeys: A potential immunotherapy for neuroendocrine tumors. Cancer Res?(2017) 77 (13_Supplement): 3633.
molnova catalog



related products
-
Forsythoside I
Forsythoside I a caffeoyl phenylethanoid glycoside (CPG) may possess anti-inflammatory activities.
-
K-Ras(G12C) Inhibito...
K-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro.
-
AICAR monophosphate
AICAR monophosphate, a purine precursor with antineoplastic activity, is important in the treatment of metabolic diseases such as type 2 diabetes as well as a possible treatment of various cancer types.